Agenda

New Paradigms in the Treatment of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia and Chronic Myeloid Leukemia

Houston, TX – April 27, 2019

7:00 AM Onsite Registration and Breakfast Buffet
7:55 AM Opening Remarks William G. Wierda, MD, PhD
Acute Lymphoblastic Leukemia (ALL)
8:00 AM Pretest – Case Vignettes TBD/Elias Jabbour, MD
8:15 AM Overview of Diagnosis Based on Cytogenetic and Molecular Abnormalities in Patients with ALL TBD
8:45 AM Novel Therapies for adolescents and young adults (AYA), Philadelphia-positive and Philadelphia-negative Relapsed/Refractory Patients with ALL Elias Jabbour, MD
9:15 AM Posttest – Case Vignettes TBD/Elias Jabbour, MD
9:30 AM BREAK
Acute Myeloid Leukemia (AML)
9:45 AM Pretest – Case Vignettes Naval G. Daver, MD / Courtney DiNardo, MD
10:00 AM Overview of Disease Classification and Prognostic Stratification in Patients with AML Naval G. Daver, MD
10:30 AM Treatment Options with Novel IDH1/2, FLT3 and CD33 Targeted Agents in Genomic Subgroups of AML Courtney DiNardo, MD
11:00 AM Posttest – Case Vignettes Naval G. Daver, MD / Courtney DiNardo, MD
Chronic Myeloid Leukemia (CML)
11:15 AM Pretest – Case Vignettes TBD/Elias Jabbour, MD
11:30 AM Response Assessment and Management of TKIs Resistance in the Management of CML TBD
12:00 PM LUNCH
1:00 PM Understanding of Time-based Response Milestones and Monitoring in Patients with CML Elias Jabbour, MD
1:30 PM Posttest – Case Vignettes TBD/Elias Jabbour, MD
Chronic Lymphocytic Leukemia (CLL)
1:45 PM Pretest – Case Vignettes Jan A. Burger, MD, PhD/ William G. Wierda, MD, PhD
2:00 PM Emerging Prognostic Markers and Risk Stratification in Treatment Decision Making for Patients with CLL Jan A. Burger, MD, PhD
2:30 PM BREAK
2:45 PM Changing the Treatment Paradigm for CLL: Chemo-immunotherapy versus Targeted Therapy William G. Wierda, MD, PhD
3:15 PM Posttest – Case Vignettes Jan A. Burger, MD, PhD/ William G. Wierda, MD, PhD
3:30 PM Closing Remarks and Adjourn William G. Wierda, MD, PhD